Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-24

Clinical Trial Update: Does High-dose Vitamin B3 Supplementation Prevent Major Adverse Kidney Events During Septic Shock? [Phase 3]

View source ↗

Summary

This update describes a Phase 3 trial assessing whether high-dose nicotinamide (Vitamin B3) can prevent major adverse kidney events in septic shock patients wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicotinamide (nicotinamide)

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Acute Kidney Injury, Septic Shock | Phase 3 | Status: ACTIVE_NOT_RECRUITING